PRME•benzinga•
Prime Medicine Announces Initial Data From First Patient Dosed In Phase 1/2 Trial Finds Single Dose Of PM359 Led To 58% 'DHR Positivity' By Day 15 And 66% By Day 30, Well Above Levels Believed To Be Potentially Curative
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 19, 2025 by benzinga